| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $407.0M | +51.9% | +201.5% |
| Cost of Revenue | $128.1M | +47.3% | +161.1% |
| Gross Profit | $278.9M | +54.0% | +224.5% |
| R&D Expense | $78.5M | +35.5% | +116.4% |
| SG&A Expense | $50.8M | +14.5% | +116.3% |
| Operating Income | $149.6M | +89.9% | +471.2% |
| Pre-tax Income | $159.1M | +90.1% | +428.3% |
| Income Tax | $1.9M | +84.8% | +157.8% |
| Net Income | $157.1M | +90.2% | +435.2% |
| EPS (Basic) | $0.86 | +83.0% | +405.9% |
| EPS (Diluted) | $0.82 | +86.4% | +412.5% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.22B | +115.0% | +307.9% |
| Short-term Investments | $81.0M | -67.1% | +1.3% |
| Accounts Receivable | $243.2M | -0.8% | +54.8% |
| Inventory | $208.0M | +38.5% | +290.7% |
| Current Assets | $1.79B | +43.7% | +188.6% |
| Total Assets | $2.04B |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $282.1M | — | — |
| Capital Expenditures | $52.5M | — | — |
| Investing Cash Flow | -$21.1M | — | — |
| Financing Cash Flow | $723.0M | — | — |
| Free Cash Flow | $229.5M | — | — |
| +183.0% |
| Current Liabilities | $165.2M | +17.7% | +104.6% |
| Total Liabilities | $188.5M | +15.5% | +85.3% |
| Stockholders' Equity | $1.85B | +43.8% | +199.1% |